Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low HDL and high triglycerides predict COVID-19 severity.
Masana L, Correig E, Ibarretxe D, Anoro E, Arroyo JA, Jericó C, Guerrero C, Miret M, Näf S, Pardo A, Perea V, Pérez-Bernalte R, Plana N, Ramírez-Montesinos R, Royuela M, Soler C, Urquizu-Padilla M, Zamora A, Pedro-Botet J; STACOV-XULA research group. Masana L, et al. Sci Rep. 2021 Mar 30;11(1):7217. doi: 10.1038/s41598-021-86747-5. Sci Rep. 2021. PMID: 33785815 Free PMC article.
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial.
Arnold SV, Hahn RT, Thourani VH, Makkar R, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O'Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran N, Garcia S, Stewart-Dehner T, Grayburn PA, Sannino A, Snyder C, Zhang Y, Mack MJ, Leon MB, Lurz P, Kodali S, Cohen DJ; TRISCEND II Pivotal Trial Investigators. Arnold SV, et al. Among authors: garcia s. J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)09954-6. doi: 10.1016/j.jacc.2024.10.067. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39480380 Free article.
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.
Hahn RT, Makkar R, Thourani VH, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O'Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran NK, Garcia S, Stewart-Dehner T, Thiele H, Kipperman R, Koulogiannis K, Lim DS, Fowler D, Kapadia S, Harb SC, Grayburn PA, Sannino A, Mack MJ, Leon MB, Lurz P, Kodali SK; TRISCEND II Trial Investigators. Hahn RT, et al. Among authors: garcia s. N Engl J Med. 2024 Oct 30. doi: 10.1056/NEJMoa2401918. Online ahead of print. N Engl J Med. 2024. PMID: 39475399
A Versatile Microfluidic Device System that Lacks a Synthetic Extracellular Matrix Recapitulates the Blood-Brain Barrier and Dynamic Tumor Cell Interaction.
Santillán-Cortez D, Castell-Rodríguez AE, González-Arenas A, Suárez-Cuenca JA, Pérez-Koldenkova V, Añorve-Bailón D, Toledo-Lozano CG, García S, Escamilla-Tilch M, Mondragón-Terán P. Santillán-Cortez D, et al. Among authors: garcia s. Bioengineering (Basel). 2024 Oct 10;11(10):1008. doi: 10.3390/bioengineering11101008. Bioengineering (Basel). 2024. PMID: 39451383 Free PMC article.
3,477 results